99 related articles for article (PubMed ID: 33398269)
1. Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes in COVID-19 convalescent plasma.
Voss WN; Hou YJ; Johnson NV; Kim JE; Delidakis G; Horton AP; Bartzoka F; Paresi CJ; Tanno Y; Abbasi SA; Pickens W; George K; Boutz DR; Towers DM; McDaniel JR; Billick D; Goike J; Rowe L; Batra D; Pohl J; Lee J; Gangappa S; Sambhara S; Gadush M; Wang N; Person MD; Iverson BL; Gollihar JD; Dye J; Herbert A; Baric RS; McLellan JS; Georgiou G; Lavinder JJ; Ippolito GC
bioRxiv; 2020 Dec; ():. PubMed ID: 33398269
[TBL] [Abstract][Full Text] [Related]
2. Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes.
Voss WN; Hou YJ; Johnson NV; Delidakis G; Kim JE; Javanmardi K; Horton AP; Bartzoka F; Paresi CJ; Tanno Y; Chou CW; Abbasi SA; Pickens W; George K; Boutz DR; Towers DM; McDaniel JR; Billick D; Goike J; Rowe L; Batra D; Pohl J; Lee J; Gangappa S; Sambhara S; Gadush M; Wang N; Person MD; Iverson BL; Gollihar JD; Dye JM; Herbert AS; Finkelstein IJ; Baric RS; McLellan JS; Georgiou G; Lavinder JJ; Ippolito GC
Science; 2021 Jun; 372(6546):1108-1112. PubMed ID: 33947773
[TBL] [Abstract][Full Text] [Related]
3. Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape.
Wang L; Shi W; Chappell JD; Joyce MG; Zhang Y; Kanekiyo M; Becker MM; van Doremalen N; Fischer R; Wang N; Corbett KS; Choe M; Mason RD; Van Galen JG; Zhou T; Saunders KO; Tatti KM; Haynes LM; Kwong PD; Modjarrad K; Kong WP; McLellan JS; Denison MR; Munster VJ; Mascola JR; Graham BS
J Virol; 2018 May; 92(10):. PubMed ID: 29514901
[TBL] [Abstract][Full Text] [Related]
4. N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2.
McCallum M; Marco A; Lempp F; Tortorici MA; Pinto D; Walls AC; Beltramello M; Chen A; Liu Z; Zatta F; Zepeda S; di Iulio J; Bowen JE; Montiel-Ruiz M; Zhou J; Rosen LE; Bianchi S; Guarino B; Fregni CS; Abdelnabi R; Caroline Foo SY; Rothlauf PW; Bloyet LM; Benigni F; Cameroni E; Neyts J; Riva A; Snell G; Telenti A; Whelan SPJ; Virgin HW; Corti D; Pizzuto MS; Veesler D
bioRxiv; 2021 Jan; ():. PubMed ID: 33469588
[TBL] [Abstract][Full Text] [Related]
5. Relationship between Anti-Spike Protein Antibody Titers and SARS-CoV-2
Salazar E; Kuchipudi SV; Christensen PA; Eagar TN; Yi X; Zhao P; Jin Z; Long SW; Olsen RJ; Chen J; Castillo B; Leveque C; Towers DM; Lavinder J; Gollihar JD; Cardona J; Ippolito GC; Nissly RH; Bird IM; Greenawalt D; Rossi RM; Gontu A; Srinivasan S; Poojary IB; Cattadori IM; Hudson PJ; Joselyn N; Prugar L; Huie K; Herbert A; Bernard DW; Dye J; Kapur V; Musser JM
bioRxiv; 2020 Jun; ():. PubMed ID: 32577662
[TBL] [Abstract][Full Text] [Related]
6. Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Based Novel Epitopes Induce Potent Immune Responses
Vishwakarma P; Yadav N; Rizvi ZA; Khan NA; Chiranjivi AK; Mani S; Bansal M; Dwivedi P; Shrivastava T; Kumar R; Awasthi A; Ahmed S; Samal S
Front Immunol; 2021; 12():613045. PubMed ID: 33841395
[TBL] [Abstract][Full Text] [Related]
7. Characterization of SARS-CoV-2 Convalescent Patients' Serological Repertoire Reveals High Prevalence of Iso-RBD Antibodies.
Curtis NC; Shin S; Hederman AP; Connor RI; Wieland-Alter WF; Ionov S; Boylston J; Rose J; Sakharkar M; Dorman DB; Dessaint JA; Gwilt LL; Crowley AR; Feldman J; Hauser BM; Schmidt AG; Ashare A; Walker LM; Wright PF; Ackerman ME; Lee J
bioRxiv; 2023 Sep; ():. PubMed ID: 37745524
[TBL] [Abstract][Full Text] [Related]
8. A proof of concept for neutralizing antibody-guided vaccine design against SARS-CoV-2.
Zhang L; Cao L; Gao XS; Zheng BY; Deng YQ; Li JX; Feng R; Bian Q; Guo XL; Wang N; Qiu HY; Wang L; Cui Z; Ye Q; Chen G; Lu KK; Chen Y; Chen YT; Pan HX; Yu J; Yao W; Zhu BL; Chen J; Liu Y; Qin CF; Wang X; Zhu FC
Natl Sci Rev; 2021 Aug; 8(8):nwab053. PubMed ID: 34676098
[TBL] [Abstract][Full Text] [Related]
9. Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike.
Liu L; Wang P; Nair MS; Yu J; Rapp M; Wang Q; Luo Y; Chan JF; Sahi V; Figueroa A; Guo XV; Cerutti G; Bimela J; Gorman J; Zhou T; Chen Z; Yuen KY; Kwong PD; Sodroski JG; Yin MT; Sheng Z; Huang Y; Shapiro L; Ho DD
Nature; 2020 Aug; 584(7821):450-456. PubMed ID: 32698192
[TBL] [Abstract][Full Text] [Related]
10. Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual.
Seydoux E; Homad LJ; MacCamy AJ; Parks KR; Hurlburt NK; Jennewein MF; Akins NR; Stuart AB; Wan YH; Feng J; Nelson RE; Singh S; Cohen KW; McElrath MJ; Englund JA; Chu HY; Pancera M; McGuire AT; Stamatatos L
bioRxiv; 2020 May; ():. PubMed ID: 32511342
[TBL] [Abstract][Full Text] [Related]
11. Neutralizing antibodies targeting the SARS-CoV-2 receptor binding domain isolated from a naïve human antibody library.
Bell BN; Powell AE; Rodriguez C; Cochran JR; Kim PS
Protein Sci; 2021 Apr; 30(4):716-727. PubMed ID: 33586288
[TBL] [Abstract][Full Text] [Related]
12. Potent Neutralizing Antibodies Directed to Multiple Epitopes on SARS-CoV-2 Spike.
Liu L; Wang P; Nair MS; Yu J; Rapp M; Wang Q; Luo Y; Chan JF; Sahi V; Figueroa A; Guo XV; Cerutti G; Bimela J; Gorman J; Zhou T; Chen Z; Yuen KY; Kwong PD; Sodroski JG; Yin MT; Sheng Z; Huang Y; Shapiro L; Ho DD
bioRxiv; 2020 Jul; ():. PubMed ID: 32587975
[TBL] [Abstract][Full Text] [Related]
13. Static all-atom energetic mappings of the SARS-Cov-2 spike protein and dynamic stability analysis of "Up" versus "Down" protomer states.
Peters MH; Bastidas O; Kokron DS; Henze CE
PLoS One; 2020; 15(11):e0241168. PubMed ID: 33170884
[TBL] [Abstract][Full Text] [Related]
14. The ACE2-binding Interface of SARS-CoV-2 Spike Inherently Deflects Immune Recognition.
Hattori T; Koide A; Noval MG; Panchenko T; Romero LA; Teng KW; Tada T; Landau NR; Stapleford KA; Koide S
J Mol Biol; 2021 Feb; 433(3):166748. PubMed ID: 33310017
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset.
Anand SP; Prévost J; Nayrac M; Beaudoin-Bussières G; Benlarbi M; Gasser R; Brassard N; Laumaea A; Gong SY; Bourassa C; Brunet-Ratnasingham E; Medjahed H; Gendron-Lepage G; Goyette G; Gokool L; Morrisseau C; Bégin P; Martel-Laferrière V; Tremblay C; Richard J; Bazin R; Duerr R; Kaufmann DE; Finzi A
bioRxiv; 2021 Jan; ():. PubMed ID: 33532774
[TBL] [Abstract][Full Text] [Related]
16. Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits.
Ravichandran S; Coyle EM; Klenow L; Tang J; Grubbs G; Liu S; Wang T; Golding H; Khurana S
Sci Transl Med; 2020 Jul; 12(550):. PubMed ID: 32513867
[TBL] [Abstract][Full Text] [Related]
17. The functions of SARS-CoV-2 neutralizing and infection-enhancing antibodies in vitro and in mice and nonhuman primates.
Li D; Edwards RJ; Manne K; Martinez DR; Schäfer A; Alam SM; Wiehe K; Lu X; Parks R; Sutherland LL; Oguin TH; McDanal C; Perez LG; Mansouri K; Gobeil SMC; Janowska K; Stalls V; Kopp M; Cai F; Lee E; Foulger A; Hernandez GE; Sanzone A; Tilahun K; Jiang C; Tse LV; Bock KW; Minai M; Nagata BM; Cronin K; Gee-Lai V; Deyton M; Barr M; Holle TV; Macintyre AN; Stover E; Feldman J; Hauser BM; Caradonna TM; Scobey TD; Rountree W; Wang Y; Moody MA; Cain DW; DeMarco CT; Denny T; Woods CW; Petzold EW; Schmidt AG; Teng IT; Zhou T; Kwong PD; Mascola JR; Graham BS; Moore IN; Seder R; Andersen H; Lewis MG; Montefiori DC; Sempowski GD; Baric RS; Acharya P; Haynes BF; Saunders KO
bioRxiv; 2021 Feb; ():. PubMed ID: 33442694
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.
McAndrews KM; Dowlatshahi DP; Dai J; Becker LM; Hensel J; Snowden LM; Leveille JM; Brunner MR; Holden KW; Hopkins NS; Harris AM; Kumpati J; Whitt MA; Lee JJ; Ostrosky-Zeichner LL; Papanna R; LeBleu VS; Allison JP; Kalluri R
JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32796155
[TBL] [Abstract][Full Text] [Related]
19. A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2.
Chi X; Yan R; Zhang J; Zhang G; Zhang Y; Hao M; Zhang Z; Fan P; Dong Y; Yang Y; Chen Z; Guo Y; Zhang J; Li Y; Song X; Chen Y; Xia L; Fu L; Hou L; Xu J; Yu C; Li J; Zhou Q; Chen W
Science; 2020 Aug; 369(6504):650-655. PubMed ID: 32571838
[TBL] [Abstract][Full Text] [Related]
20. Cross-reactive coronavirus antibodies with diverse epitope specificities and extra-neutralization functions.
Shiakolas AR; Kramer KJ; Wrapp D; Richardson SI; Schäfer A; Wall S; Wang N; Janowska K; Pilewski KA; Venkat R; Parks R; Manamela NP; Raju N; Fechter EF; Holt CM; Suryadevara N; Chen RE; Martinez DR; Nargi RS; Sutton RE; Ledgerwood JE; Graham BS; Diamond MS; Haynes BF; Acharya P; Carnahan RH; Crowe JE; Baric RS; Morris L; McLellan JS; Georgiev IS
bioRxiv; 2020 Dec; ():. PubMed ID: 33398266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
